NEW YORK (Reuters Health) – Nephron-sparing surgery is linked to better survival than radical nephrectomy for renal cell carcinoma, even among patients over age 80, study findings show.…
NEW YORK (Reuters Health) – After a first myocardial infarction, treatment with a calcium-channel blocker (CCB) does not appear to diminish the efficacy of clopidogrel, according to results…
NEW YORK (Reuters Health) – The use of artificial colloids for intravascular volume expansion is associated with greater risk of acute kidney injury and impaired coagulation than is…
NEW YORK (Reuters Health) – Children diagnosed with ulcerative colitis have a good chance of attaining remission after 1 year of treatment with azathioprine or 6-mercaptopurine, according to…
NEW YORK (Reuters Health) – Depending on the particular regimen, insulin analogs can help 35% to 64% of patients with type 2 diabetes achieve the recommended hemoglobin A1C…
NEW YORK (Reuters Health) – In the emergency department, successful intubation on the first try is equally likely using either succinylcholine at a median dose of 1.65 mg/kg…
NEW YORK (Reuters Health) – Patients with ST-elevation myocardial infarction (STEMI) who present 12 to 24 hours after onset of symptoms should be considered for reperfusion by primary…
NEW YORK (Reuters Health) – During the first year after coronary artery bypass grafting (CABG), patency rates are similar for radial artery grafts and saphenous vein grafts, study…
NEW YORK (Reuters Health) – For conversion of recent-onset atrial fibrillation, vernakalant acted more rapidly and was more effective than amiodarone in an international study. As reported in…
NEW YORK (Reuters Health) – In a prospective comparative study, 32-channel 3.0 Tesla magnetic resonance imaging (MRI) and 64-slice computed tomography (CT) angiography similarly identified significant coronary stenosis…